Related Experiment Videos
Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions
E C Hsu1, R E Dörig, F Sarangi
1Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Abstract:
CD46 was previously shown to be a primate-specific receptor for the Edmonston strain of measles virus. This receptor consists of four short consensus regions (SCR1 to SCR4) which normally function in complement regulation. Measles virus has recently been shown to interact with SCR1 and SCR2. In this study, receptors on different types of monkey erythrocytes were employed as "natural mutant proteins" to further define the virus binding regions of CD46. Erythrocytes from African green monkeys and rhesus macaques hemagglutinate in the presence of measles virus, while baboon erythrocytes were the least efficient of the Old World monkey cells used in these assays. Subsequent studies demonstrated that the SCR2 domain of baboon CD46 contained an Arg-to-Gln mutation at amino acid position 103 which accounted for reduced hemagglutination activity. Surprisingly, none of the New World monkey erythrocytes hemagglutinated in the presence of virus. Sequencing of cDNAs derived from the lymphocytes of these New World monkeys and analysis of their erythrocytes with SCR1-specific polyclonal antibodies indicated that the SCR1 domain was deleted in these cells. Additional experiments, which used 35 different site-specific mutations inserted into CD46, were performed to complement the preceding studies. The effects of these artificial mutations were documented with a convenient binding assay using insect cells expressing the measles virus hemagglutinin. Mutations which mimicked the change found in baboon CD46 or another which deleted the SCR2 glycosylation site reduced binding substantially. Another mutation which altered GluArg to AlaAla at positions 58 and 59, totally abolished binding. Finally, the epitopes for two monoclonal antibodies which inhibit measles virus attachment were mapped to the same regions implicated by mutagenesis.
Insights
Measles virus binds to specific regions of the CD46 protein, primarily SCR1 and SCR2. Mutations in these domains, like those found naturally in baboons or created artificially, significantly reduce or abolish virus binding.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- CD46 is a primate-specific receptor essential for measles virus entry.
- The Edmonston strain of measles virus utilizes specific short consensus repeat (SCR) domains of CD46 for attachment.
- Understanding CD46's interaction with measles virus is crucial for developing antiviral strategies.
Purpose of the Study:
- To precisely map the measles virus binding sites within the CD46 receptor.
- To investigate the functional significance of different CD46 domains in virus interaction.
- To identify key amino acid residues and structural features critical for measles virus attachment.
Main Methods:
- Utilized erythrocytes from various monkey species as natural CD46 variants to assess virus binding.
- Sequenced CD46 complementary DNA (cDNA) from New World monkeys to identify genetic alterations.
- Introduced 35 site-specific mutations into CD46 and evaluated binding using insect cells expressing measles virus hemagglutinin.
Main Results:
- Baboon CD46 showed reduced measles virus hemagglutination due to an Arg-to-Gln mutation in SCR2.
- New World monkey erythrocytes lacked hemagglutination, correlating with a deletion in the SCR1 domain.
- Artificial mutations mimicking natural changes or altering SCR2 glycosylation sites reduced binding; mutations at positions 58-59 abolished binding.
- Epitopes for neutralizing antibodies mapped to regions critical for virus attachment.
Conclusions:
- The SCR1 and SCR2 domains of CD46 are essential for measles virus binding.
- Specific amino acid residues and structural integrity within SCR1 and SCR2 are critical for efficient virus attachment.
- Natural variations in CD46 influence measles virus susceptibility, offering insights into host-pathogen interactions.